We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
-4.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$89.7B
AUM Growth
-$6.37B
Cap. Flow
-$1.25B
Cap. Flow %
-1.39%
Top 10 Hldgs %
19.07%
Holding
4,574
New
72
Increased
2,420
Reduced
1,279
Closed
355

Sector Composition

Rank Sector Weight
1 Technology 21.66%
2 Healthcare 16.22%
3 Financials 13.45%
4 Consumer Discretionary 9.63%
5 Industrials 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOLD
1576
DELISTED
Amicus Therapeutics
FOLD
$2.81M ﹤0.01%
269,146
+13,768
+5% +$153K
RCM
1577
DELISTED
R1 RCM Inc. Common Stock
RCM
$2.8M ﹤0.01%
151,133
+3,771
+3% +$86K
ATI icon
1578
ATI
ATI
$30.5B
$2.8M ﹤0.01%
105,138
-21,729
-17% -$605K
CRESY
1579
Cresud
CRESY
$766M
$2.79M ﹤0.01%
531,871
-93,675
-15% -$510K
MRVI icon
1580
Maravai LifeSciences
MRVI
$922M
$2.79M ﹤0.01%
109,381
+3,181
+3% +$79.8K
CLVT icon
1581
Clarivate
CLVT
$1.18B
$2.79M ﹤0.01%
296,938
-18,342
-6% -$232K
BTI icon
1582
British American Tobacco
BTI
$127B
$2.79M ﹤0.01%
78,515
+23,848
+44% +$956K
ZWS icon
1583
Zurn Elkay Water Solutions
ZWS
$8.6B
$2.79M ﹤0.01%
113,696
+2,946
+3% +$83.9K
HUBG icon
1584
HUB Group
HUBG
$2.83B
$2.78M ﹤0.01%
80,702
+18,998
+31% +$726K
OXY.WS icon
1585
Occidental Petroleum Corp Warrants
OXY.WS
$32.2B
$2.78M ﹤0.01%
70,165
CORT icon
1586
Corcept Therapeutics
CORT
$11.7B
$2.78M ﹤0.01%
108,328
+1,345
+1% +$36K
SHLS icon
1587
Shoals Technologies Group
SHLS
$1.45B
$2.78M ﹤0.01%
128,789
+7,821
+6% +$175K
ABG icon
1588
Asbury Automotive
ABG
$3.88B
$2.77M ﹤0.01%
18,365
-407
-2% -$69.3K
HPP
1589
Hudson Pacific Properties
HPP
$729M
$2.77M ﹤0.01%
36,218
-981
-3% -$95.4K
TCN
1590
DELISTED
Tricon Residential Inc.
TCN
$2.77M ﹤0.01%
319,855
-4,092
-1% -$43.2K
EBC icon
1591
Eastern Bankshares
EBC
$5.27B
$2.76M ﹤0.01%
140,476
+894
+0.6% +$17.9K
BEAM icon
1592
Beam Therapeutics
BEAM
$2.81B
$2.76M ﹤0.01%
57,868
+3,725
+7% +$212K
ETRN
1593
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$2.75M ﹤0.01%
368,438
-110,436
-23% -$924K
AXSM icon
1594
Axsome Therapeutics
AXSM
$10.8B
$2.75M ﹤0.01%
61,616
+25,413
+70% +$1.27M
FUL icon
1595
H.B. Fuller
FUL
$3.18B
$2.75M ﹤0.01%
45,694
-1,319
-3% -$84K
ELME
1596
Elme Communities
ELME
$145M
$2.73M ﹤0.01%
155,669
+1,094
+0.7% +$22.4K
ESGR
1597
DELISTED
Enstar Group
ESGR
$2.73M ﹤0.01%
16,089
+595
+4% +$116K
CRI icon
1598
Carter's
CRI
$1.48B
$2.72M ﹤0.01%
41,520
+769
+2% +$58.9K
ROIC
1599
DELISTED
Retail Opportunity Investments Corp.
ROIC
$2.72M ﹤0.01%
197,531
-113
-0.1% -$1.86K
SAM icon
1600
Boston Beer
SAM
$1.88B
$2.72M ﹤0.01%
8,394
-344
-4% -$119K

Similar funds

Credit Suisse's Q3 2022 Portfolio in Review

As of Q3 2022, Credit Suisse held 4,574 positions worth $89.7B, down 6.6% from $96.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Credit Suisse's Q3 2022 filing shows 72 new, 2,420 increased, 1,279 reduced and 355 closed positions. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 431,400 shares worth $43.3M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $205M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Credit Suisse's largest Q3 2022 buy was iShares 0-3 Month Treasury Bond ETF: 431,400 shares worth $43.3M.
  • Credit Suisse added most to Apple in Q3 2022, an estimated $180M increase.
  • Credit Suisse's biggest Q3 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $205M.
  • Credit Suisse fully exited SailPoint Technologies Holdings, Inc. Common Stock in Q3 2022, selling an estimated $40.9M.
  • Credit Suisse's ten largest holdings make up 19% of its $89.7B portfolio in Q3 2022.
  • Credit Suisse opened 72 new positions and closed 355 in Q3 2022.
  • Credit Suisse's portfolio value fell 6.6% quarter-over-quarter to $89.7B.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.